CGIX - Cancer Genetics skyrockets on acquisition of StemoniX August, 24 2020 08:54 AM Cancer Genetics Inc. Cancer Genetics (NASDAQ:CGIX) surges 231% after entering into a definitive merger agreement with privately-held StemoniX.More news on: Cancer Genetics, Inc., Healthcare stocks news, Stocks on the move, Read more ...